| Olesh Babiak, MD | |
|
30 Medical Center Blvd, Suite 305, Upland, PA 19013-3955 | |
| (610) 874-6448 | |
| Not Available |
| Full Name | Olesh Babiak |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 30 Medical Center Blvd, Upland, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821095894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 039078E (Pennsylvania) | Primary |
| Entity Name | Associates In Anesthesia, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942281191 PECOS PAC ID: 9335052034 Enrollment ID: O20031124000710 |
News Archive
Following congressional reauthorization of its funding in December 2019, the Patient-Centered Outcomes Research Institute (PCORI) began accepting new proposals for research designed to help patients and those who care for them to weigh their options and make better-informed healthcare decisions.
With sharp declines in the cost of whole genome sequencing, the day of accurately deciphering disease risk based on an individual's genome may seem at hand. But a study involving data of thousands of identical twins by Johns Hopkins investigators finds that genomic fortune-telling fails to provide informative guidance to most people about their risk for most common diseases, and warns against complacency born of negative genome test results.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic.
Last year, more than 60,000 Americans died of an opioid overdose, and millions more struggled with opioid and cocaine addiction.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Olesh Babiak, MD 30 Medical Center Blvd, Suite 305, Upland, PA 19013-3955 Ph: (610) 558-3401 | Olesh Babiak, MD 30 Medical Center Blvd, Suite 305, Upland, PA 19013-3955 Ph: (610) 874-6448 |
News Archive
Following congressional reauthorization of its funding in December 2019, the Patient-Centered Outcomes Research Institute (PCORI) began accepting new proposals for research designed to help patients and those who care for them to weigh their options and make better-informed healthcare decisions.
With sharp declines in the cost of whole genome sequencing, the day of accurately deciphering disease risk based on an individual's genome may seem at hand. But a study involving data of thousands of identical twins by Johns Hopkins investigators finds that genomic fortune-telling fails to provide informative guidance to most people about their risk for most common diseases, and warns against complacency born of negative genome test results.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic.
Last year, more than 60,000 Americans died of an opioid overdose, and millions more struggled with opioid and cocaine addiction.
› Verified 8 days ago
Phyllis Garberman Schapire, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Blvd, Suite 305, Upland, PA 19013 Phone: 610-874-6448 Fax: 610-876-7399 | |
Philip H Mclean, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Blvd, Suite 305, Upland, PA 19013 Phone: 610-874-6448 Fax: 610-876-7399 | |
Catherine J Digregorio, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Blvd, Suite 305, Upland, PA 19013 Phone: 610-874-6448 Fax: 610-876-7399 | |
Caroline Bashore, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Boulevard, Professional Office Bldg 1, Ste. 305, Upland, PA 19013 Phone: 610-874-6448 | |
Jeffrey A Nachman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Blvd, Suite 305, Upland, PA 19013 Phone: 610-874-6448 Fax: 610-876-7399 | |
Lawrence S Levit, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Blvd, Suite 305, Upland, PA 19013 Phone: 610-874-6448 Fax: 610-876-7399 | |
Meena Raman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Center Blvd, Suite 305, Upland, PA 19013 Phone: 610-874-6448 Fax: 610-876-7399 |